Citation: | ZHANG Liping, LIU Xiangjie, LIU Xiaoxia, WEI Ting, WANG Yan, LI Qian. Epidemic characteristics and disease burden of drug-resistant tuberculosis cases in the elderly in Wuhan[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 30-33. DOI: 10.7619/jcmp.20244924 |
To analyze the epidemiological characteristics and disease burden of drug-resistant tuberculosis cases among elderly patients in Wuhan.
Clinical data of elderly patients with pulmonary tuberculosis in Wuhan from January 2019 to December 2022 were retrospectively analyzed. Sputum samples were collected for Mycobacterium tuberculosis isolation, and drug susceptibility testing was performed using the proportion method. The epidemiological characteristics of drug-resistant tuberculosis and the direct economic burden of the patients were analyzed.
A total of 972 elderly patients with positive Mycobacterium tuberculosis tests were included. The overall tuberculosis drug resistance rate was 21.19% (206/972). Male, rural residence, lower education level (primary school or below) and retreatment history significantly increased the risk of developing drug-resistant tuberculosis (P < 0.05). The direct economic burden for elderly patients with drug-resistant tuberculosis was 24, 101.52 (8, 283.98, 39, 598.89) RMB, and the indirect economic burden was 1, 858.64 (528.66, 3, 085.26) RMB.
The incidence of drug resistance in elderly tuberculosis is high, and male, rural residence, low education level and tuberculosis retreatment are the risk factors for drug resistance in elderly tuberculosis, and their economic burden is heavy after drug resistance.
[1] |
范江静, 龚德华, 万燕萍, 等. 2017—2021年湖南省肺结核流行特征分析[J]. 实用预防医学, 2024, 31(1): 13-16. doi: 10.3969/j.issn.1006-3110.2024.01.004
|
[2] |
LI S C, WANG R, YANG Y, et al. Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in NorthEast China[J]. Front Pharmacol, 2023, 14: 1263726.
|
[3] |
ASSEFA D G, DEMEMEW Z G, ZELEKE E D, et al. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis[J]. BMC Public Health, 2024, 24(1): 260.
|
[4] |
MIIRO E, OLUM R, BALUKU J B. Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: a scoping review[J]. J Clin Tuberc Other Mycobact Dis, 2023, 33: 100390.
|
[5] |
DONG Z, WANG Q Q, YU S C, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006—2020[J]. Infect Dis Poverty, 2022, 11(1): 85.
|
[6] |
中华人民共和国国家卫生和计划生育委员会. 肺结核诊断标准(WS288-2017)[J]. 新发传染病电子杂志, 2018, 3(1): 59-61. doi: 10.3877/j.issn.2096-2738.2018.01.017
|
[7] |
邱巍. 结核病诊断实验室检验规程[M]. 北京: 中国文化教育出版社, 2006: 13-58.
|
[8] |
唐神结, 高文. 临床结核病学[M]. 2版. 北京: 人民卫生出版社, 2019: 201-202.
|
[9] |
麦精兰, 冯雄, 吴克长. 2016—2021年海口市新涂阳肺结核流行病学调查及耐药性监测[J]. 中国国境卫生检疫杂志, 2022, 45(5): 407-409.
|
[10] |
张娅, 张婷, 范君, 等. 2011—2022年重庆市老年利福平耐药肺结核患者的流行特征及治疗转归分析[J]. 现代预防医学, 2024, 51(6): 1099-1104.
|
[11] |
刘广天, 潘莉, 佟岩, 等. 宁夏地区耐药肺结核流行特征[J]. 现代预防医学, 2020, 47(15): 2695-2699.
|
[12] |
叶慧, 缪星国, 宋启发, 等. 温州市利福平耐药肺结核流行病学特征(2015—2020年)[J]. 国际流行病学传染病学杂志, 2022, 49(5): 320-324. doi: 10.3760/cma.j.cn331340-20220526-00121
|
[13] |
REN Y L, CHEN B, ZHAO J Y, et al. Trends of rifampicin resistance in patients with pulmonary tuberculosis: a longitudinal analysis based on drug resistance screening in Eastern China between 2015 and 2019[J]. Infect Drug Resist, 2022, 15: 7707-7717.
|
[14] |
赵慧, 王志锐, 巨韩芳, 等. 2020年天津市肺结核耐药流行病学特征及影响因素分析[J]. 疾病监测, 2023, 38(1): 57-63.
|
[15] |
LIU L, ZHAO X J, WU X Y, et al. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019[J]. BMC Microbiol, 2021, 21(1): 185.
|
[16] |
HU Y, LIU J, SHEN J, et al. Genotyping and molecular characterization of fluoroquinolone′s resistance among multidrug-resistant Mycobacterium tuberculosis in southwest of China[J]. Microb Drug Resist, 2021, 27(7): 865-870.
|
[17] |
黄海荣. 多举措并举提高结核病诊疗水平[J]. 实用医学杂志, 2022, 38(6): 660-663. doi: 10.3969/j.issn.1006-5725.2022.06.002
|
[18] |
康宏云, 商临萍, 范月玲, 等. 2015—2020年山西省耐药结核病流行特征与空间聚集性分析[J]. 疾病监测, 2023, 38(1): 34-38.
|
[19] |
杨新宇, 陈双双, 易俊莉, 等. 北京市2019年流动人口肺结核流行特征及耐药情况分析[J]. 中华流行病学杂志, 2023, 44(6): 949-953.
|
[20] |
郝冬青, 李涛, 黄飞, 等. 我国西部地区肺结核患者家庭经济负担现况调查[J]. 中国防痨杂志, 2023, 45(11): 1021-1030.
|
[21] |
吴波, 刘英, 廖文平, 等. 重庆市四区县肺结核患者经济负担分析[J]. 中国防痨杂志, 2022, 44(4): 390-396.
|
[22] |
AKALU T Y, CLEMENTS A C A, WOLDE H F, et al. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis[J]. Sci Rep, 2023, 13(1): 22361.
|
[23] |
张礼亮, 张婧怡, 田佳帅, 等. 肺结核患者疾病负担现状及影响因素研究[J]. 卫生经济研究, 2024, 41(5): 36-40.
|
[24] |
律彤, 杨云斌, 潘颖, 等. 云南省利福平耐药肺结核患者经济负担现状及影响因素分析[J]. 中国防痨杂志, 2023, 45(11): 1031-1037.
|
[25] |
FEBI A R, MANU M K, MOHAPATRA A K, et al. Psychological stress and health-related quality of life among tuberculosis patients: a prospective cohort study[J]. ERJ Open Res, 2021, 7(3): 00251-02021.
|